Showing 1 - 10 of 50,777
Persistent link: https://www.econbiz.de/10011627923
Persistent link: https://www.econbiz.de/10000147458
Persistent link: https://www.econbiz.de/10003411629
In this paper we report upon a first empirical exploration of the relative efficiency of innovation development by product users vs. product producers. In a study of over 50 years of product innovation in the whitewater kayaking field, we find users in aggregate were approximately 3X more...
Persistent link: https://www.econbiz.de/10009579600
Persistent link: https://www.econbiz.de/10009579722
This paper explores how and why collaboration with different types of partners and the position within a research network can affect firms' innovative performance in terms of product innovations. A detailed empirical analysis is carried out in the biotechnology and pharmaceutical industry. This...
Persistent link: https://www.econbiz.de/10009534096
Recent empirical contributions emphasize the importance of (potential) market size for the development of new pharmaceuticals. At the same time many scholars point out the importance of of scientific advances for the industry's R&D activities. Against this background I analyze the relationship...
Persistent link: https://www.econbiz.de/10009534102
Persistent link: https://www.econbiz.de/10009731606
This paper examines the interaction between intellectual property protection and competition policy on the choice of entrepreneurs with respect to commercialization as well as the rate of innovation. We find that stronger intellectual property protection makes it more likely that entrepreneurs...
Persistent link: https://www.econbiz.de/10009410321
A firm that lacks the specialized complementary assets necessary to commercialize an innovation faces a trade-off between contracting with an incumbent to access those assets and integrating downstream into commercialization. According to the framework developed in the prior literature, under a...
Persistent link: https://www.econbiz.de/10009419534